BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28929494)

  • 1. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Pothoulakis C; Torre-Rojas M; Duran-Padilla MA; Gevorkian J; Zoras O; Chrysos E; Chalkiadakis G; Baritaki S
    Int J Cancer; 2018 Jan; 142(2):334-346. PubMed ID: 28929494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.
    Rodriguez JA; Huerta-Yepez S; Law IK; Baay-Guzman GJ; Tirado-Rodriguez B; Hoffman JM; Iliopoulos D; Hommes DW; Verspaget HW; Chang L; Pothoulakis C; Baritaki S
    Cell Mol Gastroenterol Hepatol; 2015 Nov; 1(6):610-630. PubMed ID: 26495412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity.
    Flaherty SE; Bezy O; Zheng W; Yan D; Li X; Jagarlapudi S; Albuquerque B; Esquejo RM; Peloquin M; Semache M; Mancini A; Kang L; Drujan D; Breitkopf SB; Griffin JD; Jean Beltran PM; Xue L; Stansfield J; Pashos E; Shakey Q; Pehmøller C; Monetti M; Birnbaum MJ; Fortin JP; Wu Z
    Nat Commun; 2023 Jul; 14(1):3953. PubMed ID: 37402735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
    Jin L; Li C; Li R; Sun Z; Fang X; Li S
    J Mol Endocrinol; 2014 Jun; 52(3):255-67. PubMed ID: 24776847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced expression of CRHR2 and Sp-1 in myocardium of ovariectomized rats is improved by exercise training.
    Tang Z; Wang Y; Zhu X; Ni X; Cong B; Lu J
    Gynecol Endocrinol; 2015; 31(9):742-6. PubMed ID: 26182188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
    Tang W; Zhou W; Xiang L; Wu X; Zhang P; Wang J; Liu G; Zhang W; Peng Y; Huang X; Cai J; Bai Y; Bai L; Zhu W; Gu H; Xiong J; Ye C; Li A; Liu S; Wang J
    Nat Commun; 2019 Feb; 10(1):663. PubMed ID: 30737378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
    Zhang L; Dong X; Yan B; Yu W; Shan L
    Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
    Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
    Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
    Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
    Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of CRH, UCN, CRHR1 and CRHR2 in eutopic and ectopic endometrium of women with endometriosis.
    Vergetaki A; Jeschke U; Vrekoussis T; Taliouri E; Sabatini L; Papakonstanti EA; Makrigiannakis A
    PLoS One; 2013; 8(4):e62313. PubMed ID: 23638035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens downregulate urocortin 2 expression in rat uterus.
    Watanabe K; Nemoto T; Akira S; Takeshita T; Shibasaki T
    J Endocrinol; 2013 Dec; 219(3):269-78. PubMed ID: 24109089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells.
    Kageyama K; Murasawa S; Niioka K; Otsuka F; Yagi H; Daimon M
    Neurosci Lett; 2017 Nov; 660():63-67. PubMed ID: 28851616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortins exhibit differential effects on PGE2 and PGF2α output via CRHR2 in human myometrium.
    You X; Chen Z; Sun Q; Yao R; Gu H; Ni X
    Reproduction; 2021 May; 162(1):11-20. PubMed ID: 33929340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
    Tian JB; Cao L; Dong GL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.